Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Director/PDMR Shareholding

8 Jan 2013 17:00

Tate & Lyle PLC

Director/PDMR Shareholding

Tate & Lyle PLC (the "Company") announces that following the purchase of ordinary 25p shares ("Shares") on 4 January 2013 under the terms of the Tate & Lyle PLC Dividend Reinvestment Plan ("DRIP"), the Company was informed that the following directors of the Company have acquired interests in additional Shares at a purchase price of 791.75 pence per share:

Name No. of Shares acquired Date of notification to the Company Total No. of Shares held following purchase
Sir Peter Gershon (Chairman) 639 08/01/2013 70,138
Javed Ahmed (Chief Executive) 9,636 07/01/2013 1,050,915
Tim Lodge (Chief Financial Officer) 491 07/01/2013 53,561
Robert Walker 148 08/01/2013 11,826

This notification is made in accordance with DTR 3.1.4R(1)(a) of the FSA's Disclosure and Transparency Rules.

Lucie Gilbert

Company Secretary

8 January 2013

Copyright Business Wire 2013

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.